Implication of activated astrocytes in the development of drug dependence: Differences between methamphetamine and morphine

Annals of the New York Academy of Sciences

Volumn 1141, Issue , 2008, Pages 96-104

  Narita, Minoru ^a   Suzuki, Masami ^a   Kuzumaki, Naoko ^a   Miyatake, Mayumi ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Astrocytes; Dependence; Drugs of abuse; Glia; Synaptic plasticity

Indexed keywords

JANUS KINASE; METHAMPHETAMINE; MORPHINE; PROPENTOFYLLINE; PROTEIN KINASE C; STAT PROTEIN;

ASTROCYTE; BRAIN NERVE CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CINGULATE GYRUS; DRUG DEPENDENCE; GLIA; LOCOMOTION; NERVE CELL PLASTICITY; NEURAL STEM CELL; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; REVIEW; REWARD; SENSITIZATION;

EID: 54949129761     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1441.032     Document Type: Review

References (71)

1. Coles, J.A. & J.W. Deitmer. 2005. Extracellular potassium and pH: homeostasis and signaling. In Neuroglia. H. Kettenmann & B.R. Ransom, Eds 334 345. Oxford University Press. New York.
2. Vesce, S., P. Bezzi & A. Volterra. 2001. Synaptic transmission with the glia. News Physiol. Sci. 16 : 178 184.
3. Bohn, M.C. 2004. Motoneurons crave glial cell line-derived neurotrophic factor. Exp. Neurol. 190 : 263 275.
4. Fellin, T. & G. Carmignoto. 2004. Neuron-to-astrocyte signalling in the brain represents a distinct multifunctional unit. J. Physiol. 559 : 3 15.
5. Swanson, R.A. 2005. Astrocyte neurotransmitter uptake. In Neuroglia. H. Kettenmann & B.R. Ransom, Eds 346 354. Oxford University Press. New York.
6. Wise, R.A. & D.C. Hoffman. 1992. Localization of drug reward mechanisms by intracranial injections. Synapse 10 : 247 263.
7. 2+ influx into astrocytes. Proc. Natl. Acad. Sci. USA 87 : 3454 3458.
8. Parpura, V., T.A. Basarsky, F. Liu, et al. 1994. Glutamate-mediated astrocyte-neuron signalling. Nature 369 : 744 747.
9. Nedergaard, M., T. Takano & A.J. Hansen. 2002. Beyond the role of glutamate as a neurotransmitter. Nat. Rev. Neurosci. 3 : 748 755.
10. 2+ signalling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 447 : 247 260.
11. Fumagalli, M., R. Brambilla, N. D'Ambrosi, et al. 2003. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors. Glia 43 : 218 203.
12. Khan, Z.U., P. Koulen, M. Rubinstein, et al. 2001. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc. Natl. Acad. Sci. USA 98 : 1964 1969.
13. Reuss, B. & K. Unsicker. 2001. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes. Mol. Cell. Neurosci. 18 : 197 209.
14. Haydon, P.G. 2001. Glia: listening and talking to the synapse. Nat. Rev. Neurosci. 2 : 185 193.
15. Kang, J., L. Jiang, S.A. Goldman, et al. 1998. Astrocyte-mediated potentiation of inhibitory synaptic transmission. Nat. Neurosci. 1 : 683 692.
16. van Zundert, B., A. Yoshii & M. Constantine-Paton. 2004. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends. Neurosci. 27 : 428 437.
17. Kim, E. & M. Sheng. 2004. PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5 : 771 781.
18. Pfrieger, F.W. & B.A. Barres. 1997. Synaptic efficacy enhanced by glial cells in vitro. Science 277 : 1684 1687.
19. Ullian, E.M., S.K. Sapperstein, K.S. Christopherson, et al. 2001. Control of synapse number by glia. Science 291 : 657 661.
20. Song, H., C.F. Stevens & F.H. Gage. 2002. Astroglia induce neurogenesis from adult neural stem cells. Nature 417 : 39 44.
21. Ullian, E.M., K.S. Christopherson & B.A. Barres. 2004. Role for glia in synaptogenesis. Glia 47 : 209 216.
22. Abrous, D.N., M. Koehl & M. Le Moal. 2005. Adult neurogenesis: from precursors to network and physiology. Physiol. Rev. 85 : 523 569.
23. Hyman, S.E. & R.C. Malenka. 2001. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2 : 695 703.
24. Nestler, E.J. 2001. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2 : 119 128.
25. Self, D.W. 2004. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47 : 242 255.
26. Shippenberg, T.S., A. Herz, R. Spanagel, et al. 1992. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Ann. N. Y. Acad. Sci. 654 : 347 356.
27. De Vries, T.J. & T.S. Shippenberg. 2002. Neural systems underlying opiate addiction. J. Neurosci. 22 : 3321 3325.
28. Woolf, C.J. & Salter, M.W. 2000. Neuronal plasticity: increasing the gain in pain. Science 288 : 1765 1769.
29. Meredith, G.E., C.M. Pennartz & H.J. Groenewegen. 1993. The cellular framework for chemical signalling in the nucleus accumbens. Prog. Brain Res. 99 : 3 24.
30. Narita, M., H. Akai, Y. Nagumo, et al. 2004. Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience 127 : 941 948.
31. q/11a protein and protein kinase C during the development of sensitization to morphine-induced hyperlocomotion. Neuroscience 111 : 127 132.
32. Vanderschuren, L.J. & P.W. Kalivas. 2000. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151 : 99 120.
33. Robinson, T.E. & B. Kolb. 1999. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11 : 1598 1604.
34. Steketee, J.D. 2003. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res. Rev. 41 : 203 228.
35. Zhang, Y., T.M. Loonam, P.A. Noailles, et al. 2001. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. N. Y. Acad. Sci. 937 : 93 120.
36. Pu, C. & C.V. Vorhees. 1995. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study. Synapse 19 : 97 104.
37. Guilarte, T.R., M.K. Nihei, J.L. McGlothan, et al. 2003. Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience 122 : 499 513.
38. Narita, M., M. Miyatake, M. Shibasaki, et al. 2005. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization. J. Neurochem. 93 : 1383 1392.
39. Nishizuka, Y. 1988. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334 : 661 665.
40. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 : 607 614.
41. Powell, E.M., M.L. Mercado, Y. Calle-Patino, et al. 2001. Protein kinase C mediates neurite guidance at an astrocyte boundary. Glia 33 : 288 297.
42. Hama, H., C. Hara, K. Yamaguchi, et al. 2004. PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes. Neuron 41 : 405 415.
43. Walsh, F.S. & P. Doherty. 1996. Cell adhesion molecules and neuronal regeneration. Curr. Opin. Cell. Biol. 8 : 707 713.
44. Kuhn, T.B., M.F. Schmidt & S.B. Kater. 1995. Laminin and fibronectin guideposts signal sustained but opposite effects to passing growth cones. Neuron 14 : 275 285.
45. Bixby, J.L. & P. Jhabvala. 1992. Inhibition of tyrosine phosphorylation potentiates substrate-induced neurite growth. J. Neurobiol. 23 : 468 480.
46. Newman, E.A. 2003. New roles for astrocytes: regulation of synaptic transmission. Trends. Neurosci. 26 : 536 542.
47. 2+ oscillations in situ drive NMDAR-mediated neuronal excitation. Nat. Neurosci. 4 : 803 812.
48. Fiacco, T.A. & K.D. McCarthy. 2004. Intracellular astrocyte calcium waves in situ increase the frequency of spontaneous AMPA receptor currents in CA1 pyramidal neurons. J. Neurosci. 24 : 722 732.
49. Fellin, T., O. Pascual, S. Gobbo, et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43 : 729 743.
50. Verkhratsky, A. & H. Kettenmann. 1996. Calcium signalling in glial cells. Trends. Neurosci. 19 : 346 352.
51. Ridet, J.L., S.K. Malhotra, A. Privat, et al. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends. Neurosci. 20 : 570 577.
52. Raivich, G., M. Bohatschek, C.U. Kloss, et al. 1999. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res. Rev. 30 : 77 105.
53. Pekny, M. & M. Nilsson. 2005. Astrocyte activation and reactive gliosis. Glia 50 : 427 434.
54. Ahlemeyer, B., S. Kolker, Y. Zhu, et al. 2002. Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C. J. Neurochem. 82 : 504 515.
55. Hu, J., A. Ferreira & L.J. Van Eldik. 1997. S100b induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69 : 2294 2301.
56. Sweitzer, S.M., P. Schubert & J.A. DeLeo. 2001. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J. Pharmacol. Exp. Ther. 297 : 1210 1217.
57. Raghavendra, V., F.Y. Tanga & J.A. DeLeo. 2004. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29 : 327 334.
58. Schubert, P., T. Ogata, K. Rudolphi, et al. 1997. Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline. Ann. N. Y. Acad. Sci. 826 : 337 347.
59. Won, C.L. & Y.S. Oh. 2000. cAMP-induced stellation in primary astrocyte cultures with regional heterogeneity. Brain Res. 887 : 250 258.
60. Narita, M., M. Miyatake, M. Narita, et al. 2006. Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 31 : 2476 2488.
61. Allman, J.M., A. Hakeem, J.M. Erwin, et al. 2001. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann. N. Y. Acad. Sci. 935 : 107 117.
62. Justicia, C., C. Gabriel & A.M. Planas. 2000. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and STAT3 in astrocytes. Glia 30 : 253 270.
63. Bonni, A., Y. Sun, M. Nadal-Vicens, et al. 1997. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278 : 477 483.
64. Sriram, K., S.A. Benkovic, M.A. Herbet, et al. 2004. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? J. Biol. Chem. 279 : 19936 19947.
65. He, F., W. Ge, K. Martinowich, et al. 2005. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat. Neurosci. 8 : 616 625.
66. Hebert, M.A. & J.P. O'Callaghan. 2000. Protein phosphorylation cascades associated with methamphetamine-induced glial activation. Ann. N. Y. Acad. Sci. 914 : 238 262.
67. Färber, K. & H. Kettenmann. 2005. Physiology of microglial cells. Brain Res. Rev. 48 : 133 143.
68. 2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50 : 91 106.
69. Ryan, A.S. & B.J. Nicklas. 2004. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diab. Care 27 : 1699 1705.
70. Kapasi, A.A., N. Gibbons, J. Mattana, et al. 2000. Morphine stimulates mesangial cell TNF-α and nitrite production. Inflammation 24 : 463 476.
71. Lee, Y.W., B. Hennig, J. Yao, et al. 2001. Methamphetamine induces AP-1 and NF-kB binding and transactivation in human brain endothelial cells. J. Neurosci. Res. 66 : 583 591.